^M Santoro, N A Dathan, M T Berlingieri, I Bongarzone, C Paulin, M Grieco, M A Pierotti, G Vecchio, A Fusco (February 1994). “Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma”. Oncogene9 (2): 509–16. PMID8290261.
^Philippe Alen, Frank Claessens, Erik Schoenmakers, Johannes V. Swinnen, Guido Verhoeven, Wilfried Rombauts, Ben Peeters (1 January 1999). “Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform”. Molecular Endocrinology13 (1): 117–28. doi:10.1210/mend.13.1.0214. PMID9892017.
^Zhong-xun Zhou, Bin He, Susan H. Hall, Elizabeth M. Wilson, Frank S. French (1 February 2002). “Domain interactions between coregulator ARA(70) and the androgen receptor (AR)”. Molecular Endocrinology16 (2): 287–300. doi:10.1210/mend.16.2.0765. PMID11818501.
^Bin He, John T. Minges, Lori W. Lee, Elizabeth M. Wilson (22 March 2002). “The FXXLF motif mediates androgen receptor-specific interactions with coregulators”. The Journal of Biological Chemistry277 (12): 10226–35. doi:10.1074/jbc.M111975200. PMID11779876.
^Tianshu Gao, Ken Brantley, Erol Bolu, Michael J. McPhaul (1 October 1999). “RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays”. Molecular Endocrinology13 (10): 1645–56. doi:10.1210/mend.13.10.0352. PMID10517667.
^Cynthia A. Heinlein, Huei-Ju Ting, Shuyuan Yeh, Chawnshang, Chang (4 June 1999). “Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma”. The Journal of Biological Chemistry274 (23): 16147–52. doi:10.1074/jbc.274.23.16147. PMID10347167.
^William E. Dowdle, Beat Nyfeler, Jane Nagel, Robert A. Elling, Shanming Liu, Ellen Triantafellow, Suchithra Menon, Zuncai Wang, Ayako Honda, Gwynn Pardee, John Cantwell, Catherine Luu, Ivan Cornella-Taracido, Edmund Harrington, Peter Fekkes, Hong Lei, Qing Fang, Mary Ellen Digan, Debra Burdick, Andrew F. Powers, Stephen B. Helliwell, Simon D’Aquin, Julie Bastien, Henry Wang, Dmitri Wiederschain, Jenny Kuerth, Philip Bergman, David Schwalb, Jason Thomas, Savuth Ugwonali, Fred Harbinski, John Tallarico, Christopher J. Wilson, Vic E. Myer, Jeffery A. Porter, Dirksen E. Bussiere, Peter M. Finan, Mark A. Labow, Xiaohong Mao, Lawrence G. Hamann, Brendan D. Manning, Reginald A. Valdez, Thomas Nicholson, Markus Schirle, Mark S. Knapp, Erin P. Keaney & Leon O. Murphy (19 November 2014). “Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo”. Nature Cell Biology16 (11): 1069–79. doi:10.1038/ncb3053. PMID253272886
^Roberto Bellelli, Giorgia Federico, Alessandro Matte', David Colecchia, Achille Iolascon, Mario Chiariello, Massimo Santoro, Lucia De Franceschi, Francesca Carlomagno (26 January 2016). “NCOA4 Deficiency Impairs Systemic Iron Homeostasis”. Cell Reports14 (3): 411–421. doi:10.1016/j.celrep.2015.12.065. PMID26776506.